Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company ...

"New BD," built on momentum of BD 2025 strategy, will be well-positioned as a scaled, pure-play MedTech leader focused on attractive categories shaping the future of health care Biosciences and ...

Feb 5 (Reuters) - (This Feb. 5 story has been refiled to correct the name of the unit to biosciences and diagnostic solutions, from life sciences, in the headline and paragraphs 1 and 4 ...

We believe Biosciences and Diagnostic Solutions is expected to deliver substantial value as a pure-play leader in life sciences and will be well-positioned to execute on its unique and compelling ...

On 98% of research and impact from the School of Biosciences is rated as world-leading or internationally excellent. Research Excellence Framework, 2021 Some of the projects below come with specific ...

After hours: February 21 at 7:59:12 PM EST Loading Chart for CHRS ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

Story Jan. 10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM ...

Welcome to the Department of Biosciences. The department delivers innovative, TEF Gold standard teaching and research in subjects including biomedical science, microbiology, biochemistry, pharmacology ...